Patients aged ≥18 years with reduced LVEF ≤45% in three registries were eligible for the present study. The subjects without information on height and weight were excluded. Underweight HF patients may have "cardiac cachexia," which is known to be associated with worse prognosis; thus, to adjust for the potential confounding effect of patients with cachexia or frailty, those classified as underweight (BMI <18.5 kg/m 2 ) were excluded from the analysis. 9 According to the World Health Organization criteria, overweight was defined as a BMI of ≥25 kg/m 2 . 10 The selection of the study population is described in Fig. 1 .
Endpoints
The study endpoints included 1-year all-cause mortality and 1-year re-hospitalization. Given the nature of systolic HF, which is frequently aggravated by trivial triggers and require hospitalization, any re-hospitalization was selected as an endpoint. Owing to ambiguity in distinguishing cardiac death from noncardiac death in systolic HF, we also chose all-cause mortality as a study endpoint, instead of cardiac death.
Statistical analysis
Statistical analyses were conducted using SPSS version 20.0 (IBM Corp., Armonk, NY, USA). Continuous variables were expressed as mean±standard deviation. Categorical variables were expressed as absolute numbers and percentages. All analyses were performed separately according to sex. To adjust for significant covariates, multivariable models were developed for all-cause mortality and re-hospitalization. We used binary logistic regression models to estimate unadjusted and adjusted relationships between each variable and patient outcomes. The adjusted model was controlled for baseline demographic and clinical characteristics. These included age, hypertension, diabetes mellitus (DM), ischemic HF, previous myocardial infarction (MI), EF, serum creatinine (Cr) level, and anemia [hemoglobin (Hb) <10 g/dL]. Kaplan-Meier analyses were used to compare between endpoints. The log-rank test was used to test for differences in unadjusted survival curves. A two-sided p-value of <0.05 was considered significant.
RESULTS

Demographics
Finally, 2484 patients (men, 1443; women, 1041) were included in the present study (Fig. 1) 
Clinical outcomes
Among the 3251 subjects, 2484 (76.4%; men, 1483; women, 1041) had available information on the study endpoints (Table  3) . In men, a larger proportion of patients in the normal BMI group than in the high BMI group (40.3% vs. 29.4%, p<0.001) reached the study endpoints. One-year all-cause mortality (17.2% vs. 6.9%, p<0.001) and re-hospitalization rates (31.0% vs. 25.4%, p=0.024) were significantly higher in the normal BMI group than in the high BMI group. Meanwhile, no significant differences in study endpoints were found between women in the normal BMI group and those in the high BMI group (37.7% vs. 35.4%, p=0.544). No significant differences in all-cause mortality and re-hospitalization rates were found between the two groups. The Kaplan-Meier event free curves of each study endpoints are depicted in Fig. 2 the normal BMI group. However, no significant differences in the study endpoints were observed between the two groups of women ( Fig. 3) . After adjustment for age, hypertension, DM, ischemic HF, previous MI, serum Cr level, hemoglobin, and EF, the odds ratios for the study endpoints were 0.786 [95% confidence interval (CI), 0.620−0.998] and 0.545 (95% CI, 0.302−0.985), respectively, in males. However, among women, those with high BMI were not associated with either of the study endpoints, even after adjustment (Table 4) .
DISCUSSION
The present study demonstrated the existence of the obesity paradox and a sex-related difference in the obesity paradox in systolic HF. To date, many studies have demonstrated the obesity paradox in systolic HF. Unfortunately, the mechanism of the obesity paradox remains unclear. Multiple explanations have been proposed for the obesity paradox in HF. Cardiac cachexia is one of the representative explanations for the obesity paradox. Systolic HF is well known to be a catabolic status. 11 Cardiac cachexia was previously shown to be associated with neurohormonal imbalance, inflammation, and poor progno- .4) 0.983 BMI, body mass index; SBP, systolic blood pressure; BPM, beats per minute; HF, heart failure; LBBB, left bundle branch block; NYHA, New York Heart Association; HTN, hypertension; DM, diabetes mellitus; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; BUN, blood urea nitrogen; Cr, creatinine; BNP, brain natriuretic peptides; NT-proBNP, N terminal pro brain natriuretic peptides; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonist. Values are expressed as mean±SD or n (%). of obesity has also been suggested, such as decreased catecholamine response and high cholesterol level, which has an anti-inflammatory property to neutralize circulating lipopolysaccharides. 15, 16 Adipose tissue is known to produce soluble tumor necrosis factor (TNF)-alpha receptors, which could have a protective effect in obese patients with HF by neutralizing the adverse effect of TNF. 17 The present study demonstrated a clear sex-related difference in the obesity paradox in a large number of patients with systolic HF. However, the sex-related difference in the obesity paradox has not been clearly understood yet. Recently, a neurohormonal sex-related difference in HF was reported. 18 The levels of biomarkers related to inflammation and extracellular matrix remodeling were found to be significantly lower in women than in men. Considering the anti-inflammatory effect of obesity, the protective effect of obesity might be more prominent in men than in women. The sex-related difference in systolic HF was demonstrated in a previous study. 2 In the study, high BMI and waist circumference did not predict improved survival in women. However, the number of female subjects were so small (n=94) that it had limited power to detect any difference. Some studies suggest differences of gender in obesity and its effects, awareness of symptoms, and medical treatment in patients with cardiac diseases, including HF. There was a gender difference between obesity and associates of HF symptoms. 19 In a study of the effects of obesity on myocardial and vascular stiffness, myocardial hypertrophy in males was different from that in females. 20 Male patients were better at interpreting their HF symptoms, compared to female patients. 21 Thus, the relationship between obesity and HF may differ in male and female patients. In 2014, Shah, et al. 22 performed a 1-year prospective global registry to explore the obesity paradox in HF, and revealed that the inverse association was stronger in subjects with older age, nondiabetes, or systolic HF. In addition, the study showed a racial difference wherein the inverse BMI association with mortality was stronger in Asian patients than in European and American patients. Previous study of the obesity paradox in patients with HF showed contradictory results with our study. 23 While it is difficult to explain the reason, the overweight group in the study, not the obese group, showed survival advantage in the study. We suspect that various factors may have affected the results, such as se- Follow-up (days) Fig. 2 . Kaplan-Meier curve for incidence of the primary endpoint in the male population. BMI, body mass index.
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Log rank p=0.003 lection bias or race, etc. BMI is the most commonly used epidemiologic measure of obesity. Most studies regarding the obesity paradox used BMI to measure adiposity. However, BMI also reflects lean body mass. We excluded underweight from analysis to adjust for potent confounding factors. 22, 24 To better measure pure adiposity, waist circumference has been used in several previous studies to understand the obesity paradox in HF. However, waist circumference has a limitation in that it cannot be used to distinguish between visceral and subcutaneous fats, which have different properties in the human body. To know which kind of adiposity is more related to the obesity paradox, further investigations using imaging studies are needed. In the present study, additional analysis using waist circumference could not be performed because of the lack of data.
Out study has several limitations. All the subjects were hospitalized for acute decompensated HF at study enrollment. Thus, body weight could be measured in terms of fluid retention status. We merged two registries designed for different purposes. However, we believe a large number of subjects could be enough to cover this limitation. We did not have information on the use of inotropics or cholesterol and cytokine levels, which would be helpful to understand the pathophysiology of the obesity paradox. Lastly, this study was conducted as a retrospective analysis, and pre-hospital course or detailed symptoms were not specified. The distribution of many of the variables between the groups was largely uneven; however, this is a natural characteristic of registry studies.
In conclusion, in the pooled analysis of data from two Korean HF registries, obesity (high BMI) was independently associated with lower 1-year mortality rate in systolic HF in men, but not in women. A sex-related difference in the obesity paradox in systolic HF was confirmed. To understand the pathophysiology of the obesity paradox, further investigation is needed.
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